arcadia

LUPIN LTD.

NSE : LUPINBSE : 500257ISIN CODE : INE326A01037Industry : Pharmaceuticals & DrugsHouse : Lupin
BSE863.4510.85 (+1.27 %)
PREV CLOSE ( ) 852.60
OPEN PRICE ( ) 855.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 863.45 (300)
VOLUME 105927
TODAY'S LOW / HIGH ( )854.05 869.00
52 WK LOW / HIGH ( )723.55 986
NSE864.7010.95 (+1.28 %)
PREV CLOSE( ) 853.75
OPEN PRICE ( ) 857.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 864.70 (2266)
VOLUME 1154745
TODAY'S LOW / HIGH( ) 855.45 869.90
52 WK LOW / HIGH ( )723.65 986.1
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 01-03 1983
Management Info
Manju D Gupta - Chairman Nilesh Deshbandhu Gupta - Managing Director
Registered Office

Address Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East),
Mumbai,
Maharashtra-400055

Phone 022 6640 2323

Email info@lupinworld.com

Website www.lupinworld.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
15Nov Lupin receives USFDA's approval for De
Lupin has received approval for its Decitabine for Injection, 50 mg/vial..
15Nov Lupin gains on receiving USFDA's appro
Lupin is currently trading at Rs. 848.10, up by 6.80 points or 0.81% fro..
13Nov Lupin receives USFDA approval for Bude
Lupin has received approval for its Budesonide Inhalation Suspension, 0...
13Nov Lupin informs about press release
Lupin has informed about a Press Release as regards receipt of USFDA app..
12Nov Lupin's Nagpur facility receives EIR f
Lupin has received the Establishment Inspection report (EIR) post the co..
Financials
Rs. in Millions
QTR Sep 18 ANNUAL 18
Net Profit4247.513446.6
Gross Profit 5801.8 17939.3
Operating Profit 6950.522169.8
Net Sales 27125.5100881.8
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Piramal Enterprises (BSE)
 2341.50 (2.26%)
M.Cap ( in Cr)42933.70
Pfizer (BSE)
 2828.80 (1.80%)
M.Cap ( in Cr)12941.12
Merck (BSE)
 3027.35 (1.36%)
M.Cap ( in Cr)5025.21
Ajanta Pharma (BSE)
 1119.65 (3.36%)
M.Cap ( in Cr)9855.50
Divis Lab (BSE)
 1554.45 (1.54%)
M.Cap ( in Cr)41265.76
Shareholding Pattern
PROMOTERS 47%
NON-INSTITUTION 15.3%
MUTUAL FUNDS/UTI 6.5%
FI/BANKS/INSURANCE 5.54%
GOVERNMENT 0.26%
FII 0%
Attention Investors

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number and Email address with your Depository Participant. Receive alerts on your Registered Mobile and Email address for all debit and other important transactions in your demat account directly from CDSL on the same day..... issued in the interest of investors."

ARCADIA SHARE & STOCK BROKERS PVT. LTD.

MEMBER NSE (CASH & DERIVATIVES) : INB/F_230778238

MEMBER BSE (CASH) : INB010778232

MEMBER CDSL DP : IN225

ARCADIA COMMODITIES & TRADING

MEMBER MCX : 10950

MEMBER NCDEX : 00374 & FMC – MCX/TCM/PART/0503 & FMC –NCDEX/TCM/PART/0356 & ACE COMMODITY EXCHANGE MEMBER ID –

6090 FMC – ACE/TCM/PART/0252 & NSEL MEMBER - 14120 SEBI- NCDEX - INZ000048620

Copyright © 2017 Arcadia Share & Stock Brokers Pvt. Ltd.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

GO TO TOP
CLOSE X
Exclusive Email address for the Customer Grievance dphelp@arcadiashare.com
CLOSE

COMPLAINTS FORM